Shareholders of Pfizer have reason to be happy. The stock moved up today - after falling steadily in recent weeks - as the management predicted further growth in the consumer health unit. Meanwhile, profit and turnover rose in the first quarter, to a greater extent than experts thought.
I think they realized how valuable the consumer business was after they sold the Parke-Davis consumer division. IT WAS A GOLD MINE!!!!!! and for Pfizer LOST TREASURE!!!!!